Level Chart

Level Chart

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 11.20%, compared to 16.10% last quarter and 25.60% last year. This is lower than the long term average of 12.83%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 11.20%
Latest Period Mar 2026
Last Updated Jul 29 2026, 08:30 EDT
Next Release Oct 21 2026, 08:30 EDT (E)
Long Term Average 12.83%
Average Growth Rate 180.1%
Value from Last Quarter 16.10%
Change from Last Quarter -30.43%
Value from 1 Year Ago 25.60%
Change from 1 Year Ago -56.25%
Frequency Quarterly
Unit Percent
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 11.20%
December 31, 2025 16.10%
September 30, 2025 19.40%
June 30, 2025 23.20%
March 31, 2025 25.60%
December 31, 2024 27.40%
September 30, 2024 24.60%
June 30, 2024 19.00%
March 31, 2024 16.30%
December 31, 2023 13.30%
September 30, 2023 10.60%
June 30, 2023 13.40%
March 31, 2023 14.40%
Date Value
December 31, 2022 9.40%
September 30, 2022 12.60%
June 30, 2022 7.80%
March 31, 2022 10.80%
December 31, 2021 27.00%
September 30, 2021 18.50%
June 30, 2021 47.20%
March 31, 2021 7.40%
December 31, 2020 -13.50%
September 30, 2020 -10.40%
June 30, 2020 -25.30%
March 31, 2020 -2.50%
December 31, 2019 10.00%

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 11.20%, compared to 16.10% last quarter and 25.60% last year. This is lower than the long term average of 12.83%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 11.20%
Latest Period Mar 2026
Last Updated Jul 29 2026, 08:30 EDT
Next Release Oct 21 2026, 08:30 EDT (E)
Long Term Average 12.83%
Average Growth Rate 180.1%
Value from Last Quarter 16.10%
Change from Last Quarter -30.43%
Value from 1 Year Ago 25.60%
Change from 1 Year Ago -56.25%
Frequency Quarterly
Unit Percent
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp. 1.81%